VolitionRx Limited Extends Clinical Trial Program in Lung Cancer
Go back to VolitionRx Limited Extends Clinical Trial Program in Lung Cancer| VolitionRX Limited (NYSE: VNRX) | Delayed: 0.34 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.34 | 52 Week High | $5.86 | |||
| Open | $0.35 | 52 Week Low | $3.05 | |||
| Day High | $0.35 | P/E | N/A | |||
| Day Low | $0.33 | EPS | $-0.45 | |||
| Volume | 939,251 | |||||
